ELI LILLY & Co·4

Feb 11, 4:20 PM ET

Montarce Lucas 4

4 · ELI LILLY & Co · Filed Feb 11, 2026

Research Summary

AI-generated summary of this filing

Updated

Eli Lilly CFO Montarce Lucas Receives Award of 1,365 Shares

What Happened
Montarce Lucas, Executive Vice President & Chief Financial Officer of Eli Lilly & Co. (LLY), was granted/received 1,365.47 shares on February 9, 2026. The reported acquisition price/value per share was $1,044.67, for a total reported value of $1,426,466. This transaction is reported on a Form 4 as an award/grant (transaction code A), which typically reflects company compensation (e.g., restricted stock or similar), not an open-market purchase or sale.

Key Details

  • Transaction date: 2026-02-09; Form 4 filed: 2026-02-11 (appears timely under the two-business-day Form 4 filing rule).
  • Transaction type/code: A — Award/Grant or other acquisition.
  • Shares acquired: 1,365.47; price/value per share: $1,044.67; total value: $1,426,466.
  • Post-transaction shares owned: Not specified in the information provided.
  • No footnotes, 10b5-1 plan, or tax-withholding detail was included in the supplied data.

Context
An "A" award/grant typically reflects compensation vesting or a one-time grant from the company and does not necessarily signal the insider purchasing stock with personal funds. Such grants are common for executives as part of pay packages; they are informative about compensation but should not be read as a straightforward bullish market signal.

Insider Transaction Report

Form 4
Period: 2026-02-09
Transactions
  • Award

    Common Stock

    2026-02-09$1044.67/sh+1,365.47$1,426,46616,050.206 total
Signature
/s/ Jonathan Groff for Lucas E. Montarce, pursuant to authorization on file|2026-02-11

Documents

1 file
  • 4
    wk-form4_1770844810.xmlPrimary

    FORM 4